XML 20 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 2,177 $ 1,975
Accounts receivables, net of allowance for credit losses of $126 million and $135 million as of December 31, 2020 and December 31, 2019 4,581 5,676
Inventories 4,403 4,422
Prepaid expenses 945 870
Other current assets 710 434
Assets held for sale 189 87
Total current assets 13,005 13,464
Deferred income taxes 695 386
Other non-current assets 538 591
Property, plant and equipment, net 6,296 6,436
Operating lease right-of-use assets 559 514
Identifiable intangible assets, net 8,923 11,232
Goodwill [1] 20,624 24,846
Total assets 50,640 57,470
Current liabilities:    
Short-term debt 3,188 2,345
Sales reserves and allowances 4,824 6,159
Accounts payables 1,756 1,718
Employee-related obligations 685 693
Accrued expenses 1,780 1,869
Other current liabilities 933 889
Total current liabilities 13,164 13,674
Long-term liabilities:    
Deferred income taxes 964 1,096
Other taxes and long-term liabilities 2,240 2,640
Senior notes and loans 22,731 24,562
Operating lease liabilities 479 435
Total long-term liabilities 26,414 28,733
Commitments and contingencies, see note 12  
Total liabilities 39,579 42,407
Teva shareholders' equity:    
Ordinary shares of NIS 0.10 par value per share; December 31, 2020 and December 31, 2019: authorized 2,495 million shares; issued 1,202 million shares and 1,198 million shares, respectively 57 56
Additional paid-in capital 27,443 27,312
Accumulated deficit (10,946) (6,956)
Accumulated other comprehensive loss (2,399) (2,312)
Treasury shares as of December 31, 2020 and December 31, 2019: 106 million ordinary shares (4,128) (4,128)
Stockholders' equity attributable to Teva shareholders 10,026 13,972
Non-controlling interests 1,035 1,091
Total equity 11,061 15,063
Total liabilities and equity $ 50,640 $ 57,470
[1] Accumulated goodwill impairment as of December 31, 2020, December 31, 2019 and December 31, 2018 was approximately $25.6 billion, $21.0 billion and $21.0 billion, respectively.